Stefania Lamon-Fava

Stefania Lamon-Fava

Auto-generated profile, based on publicly available information

Stefania Lamon-Fava

Cardiovascular Nutrition Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2010 in Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
MCMichael P Corcoran
Michael P Corcoran
MMMohsen Meydani
Mohsen Meydani
ALAlice H Lichtenstein
Alice H Lichtenstein
ESErnst J Schaefer
Ernst J Schaefer
ADAlice Dillard
Alice Dillard
SLStefania Lamon-Fava
Stefania Lamon-Fava
Inflammation plays a central role in the development and progression of coronary heart disease (CHD). The sex hormones estrogen and testosterone have been shown to modify the inflammatory response by influencing cytokine expression in human macrophages obtained from younger individuals. The effect of these hormones on the expression of proinflammatory markers in macrophages obtained from a CHD age-relevant population has not been studied. Human monocyte-derived macrophages (HMDMs) were obtained from healthy normolipidemic men and postmenopausal women (age 50–70 years), and cultured in autologous serum along with both physiological and supraphysiological concentrations of estrogen or testosterone. HMDMs were stimulated with oxidized low-density lipoproteins, and the expression of the cytokines tumor necrosis factor α (TNF-α or TNF), interleukin (IL)6, and IL-1β (IL1B) and of the acute-phase protein C-reactive protein (CRP) was measured. Both physiological and supraphysiological concentrations of testosterone reduced the expression and secretion of TNF-α and reduced the expression of IL-1β, but did not affect the expression of IL6 or CRP. Estrogen did not modify the expression of TNF-α, IL6, and IL-1β. Estrogen caused a variable response in CRP expression that was positively associated with the plasma small dense LDL-cholesterol concentration of the donors. There were no gender differences in any of the observed effects. Our results indicate that testosterone may exert anti-inflammatory effects by reducing macrophage TNF-α expression, while the effects of estrogen on macrophage CRP expression may depend upon the extracellular lipid environment.

1 January 2021 in Atherosclerosis
Verified
Journal Article
Closed access
JSJisun So
Jisun So
DWDayong Wu
Dayong Wu
ALAlice H Lichtenstein
Alice H Lichtenstein
ATAlbert K. Tai
Albert K. Tai
NMNirupa R. Matthan
Nirupa R. Matthan
SLStefania Lamon-Fava
Stefania Lamon-Fava

1 September 2008 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
SLStefania Lamon-Fava
Stefania Lamon-Fava
MDMargaret R. Diffenderfer
Margaret R. Diffenderfer
PBP. Hugh R. Barrett
P. Hugh R. Barrett
ABAaron Buchsbaum
Aaron Buchsbaum
MNMawuli Nyaku
Mawuli Nyaku
ESErnst J. Schaefer
Ernst J. Schaefer
Objectives— Extended-release niacin effectively lowers plasma TG levels and raises plasma high-density lipoprotein (HDL) cholesterol levels, but the mechanisms responsible for these effects are unclear. Methods and Results— We examined the effects of extended-release niacin (2 g/d) and extended-release niacin (2 g/d) plus lovastatin (40 mg/d), relative to placebo, on the kinetics of apolipoprotein (apo) A-I and apoA-II in HDL, apoB-100 in TG-rich lipoproteins (TRL), intermediate-density lipoproteins (IDL) and low-density lipoproteins (LDL), and apoB-48 in TRL in 5 men with combined hyperlipidemia. Niacin significantly increased HDL cholesterol and apoA-I concentrations, associated with a significant increase in apoA-I production rate (PR) and no change in fractional catabolic rate (FCR). Plasma TRL apoB-100 levels were significantly lowered by niacin, accompanied by a trend toward an increase in FCR and no change in PR. Niacin treatment significantly increased TRL apoB-48 FCR but had no effect on apoB-48 PR. No effects of niacin on concentrations or kinetic parameters of IDL and LDL apoB-100 and HDL apoA-II were noted. The addition of lovastatin to niacin promoted a lowering in LDL apoB-100 attributable to increased LDL apoB-100 FCR. Conclusion— Niacin treatment was associated with significant increases in HDL apoA-I concentrations and production, as well as enhanced clearance of TRL apoB-100 and apoB-48.

1 September 2014 in Physiological Genomics
Verified
Journal Article
Open access
PDF file
APAnna C. Pfalzer
Anna C. Pfalzer
SCSang-Woon Choi
Sang-Woon Choi
STStephanie A. Tammen
Stephanie A. Tammen
LPLara K. Park
Lara K. Park
TBTeodoro Bottiglieri
Teodoro Bottiglieri
SLStefania Lamon-Fava
Stefania Lamon-Fava
S-adenosylmethionine (SAM), the unique methyl donor in DNA methylation, has been shown to lower lipopolysaccharide (LPS)-induced expression of the proinflammatory cytokine TNF-α and increase the expression of the anti-inflammatory cytokine IL-10 in macrophages. The aim of this study was to assess whether epigenetic mechanisms mediate the anti-inflammatory effects of SAM. Human monocytic THP1 cells were differentiated into macrophages and treated with 0, 500, or 1,000 μmol/l SAM for 24 h, followed by stimulation with LPS. TNFα and IL-10 expression levels were measured by real-time PCR, cellular concentrations of SAM and S-adenosylhomocysteine (SAH), a metabolite of SAM, were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS), and DNA methylation was measured with LC-MS/MS and microarrays. Relative to control (0 μmol/l SAM), treatment with 500 μmol/l SAM caused a significant decrease in TNF-α expression (−45%, P < 0.05) and increase in IL-10 expression (+77%, P < 0.05). Treatment with 1,000 μmol/l SAM yielded no significant additional benefits. Relative to control, 500 μmol/l SAM increased cellular SAM concentrations twofold without changes in SAH, and 1,000 μmol/l SAM increased cellular SAM sixfold and SAH fourfold. Global DNA methylation increased 7% with 500 μmol/l SAM compared with control. Following treatment with 500 μmol/l SAM, DNA methylation microarray analysis identified 765 differentially methylated regions associated with 918 genes. Pathway analysis of these genes identified a biological network associated with cardiovascular disease, including a subset of genes that were differentially hypomethylated and whose expression levels were altered by SAM. Our data indicate that SAM modulates the expression of inflammatory genes in association with changes in specific gene promoter DNA methylation.

1 June 2011 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
SLStefania Lamon-Fava
Stefania Lamon-Fava
SMSantica M. Marcovina
Santica M. Marcovina
JAJohn J. Albers
John J. Albers
HKHal Kennedy
Hal Kennedy
CDCarl DeLuca
Carl DeLuca
ESErnst J. Schaefer
Ernst J. Schaefer
Stefania Lamon-Fava, Santica M. Marcovina, John J. Albers, Hal Kennedy, Carl DeLuca, Charles C. White, L. Adrienne Cupples, Judith R. McNamara, Leo J. Seman, Vanina Bongard, Ernst J. Schaefer

1 August 2007 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
SLStefania Lamon-Fava
Stefania Lamon-Fava
MDMargaret R. Diffenderfer
Margaret R. Diffenderfer
PBP. Hugh R. Barrett
P. Hugh R. Barrett
ABAaron Buchsbaum
Aaron Buchsbaum
NMNirupa R. Matthan
Nirupa R. Matthan
ESErnst J. Schaefer
Ernst J. Schaefer
Stefania Lamon-Fava, Margaret R. Diffenderfer, P. Hugh R. Barrett, Aaron Buchsbaum, Nirupa R. Matthan, Alice H. Lichtenstein, Gregory G. Dolnikowski, Katalin Horvath, Bela F. Asztalos, Valeria Zago, Ernst J. Schaefer